gyrodyne_8k-120911.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

--------------------

Date of Report (Date of earliest event reported):  December 9, 2011
--------------

GYRODYNE COMPANY OF AMERICA, INC.
---------------------------------
(Exact name of Registrant as Specified in its Charter)
 
New York    000-01684  11-1688021
         
 
(State or other jurisdiction (Commission File  (I.R.S. Employer
of incorporation)   Number)   Identification No.)
 
ONE FLOWERFIELD
SUITE 24
ST. JAMES, NEW YORK 11780
-------------------------
(Address of principal executive
offices) (Zip Code)

(631) 584-5400
--------------
Registrant’s telephone number,
including area code

N/A
----------------------
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17  CFR 240.14d-2(b))
 
[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 

Item 7.01.  Regulation FD Disclosure

The Company’s President gave a presentation to the Company’s shareholders at its 2011 Annual Shareholders Meeting held on December 9, 2011.  The script of the President’s presentation is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01.  Financial Statements and Exhibits

   (d)      Exhibits

         Exhibit No.      Exhibit
         -----------      ---------------

99.1      Script of President’s Presentation.
 
 
 

 
 
SIGNATURE

         Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



                                                       GYRODYNE COMPANY OF AMERICA, INC.


                                         By: /s/ Stephen V. Maroney
                                         -----------------------------------------------
                                         Stephen V. Maroney
                                         President and Chief Executive Officer
 
 
Date:  December 9, 2011